228 related articles for article (PubMed ID: 1460848)
1. Evaluation of greyhound susceptibility to malignant hyperthermia using halothane-succinylcholine anesthesia and caffeine-halothane muscle contractures.
Cosgrove SB; Eisele PH; Martucci RW; Gronert GA
Lab Anim Sci; 1992 Oct; 42(5):482-5. PubMed ID: 1460848
[TBL] [Abstract][Full Text] [Related]
2. Malignant hyperthermia in dogs.
Nelson TE
J Am Vet Med Assoc; 1991 Mar; 198(6):989-94. PubMed ID: 2032926
[TBL] [Abstract][Full Text] [Related]
3. Porcine malignant hyperthermia: false negatives in the halothane test.
Gallant EM; Rempel WE
Am J Vet Res; 1987 Mar; 48(3):488-91. PubMed ID: 3565905
[TBL] [Abstract][Full Text] [Related]
4. Atypical reactions to halothane in a subgroup of homozygous malignant hyperthermia(MH)-susceptible pigs: indication of a heterogenous genetic basis for the porcine syndrome.
Richter A; Gerdes C; Löscher W
Dtsch Tierarztl Wochenschr; 1992 Oct; 99(10):401-6. PubMed ID: 1425316
[TBL] [Abstract][Full Text] [Related]
5. [The action of ketamine on muscle contractile behavior. In vitro studies on the musculature of subjects susceptible to malignant hyperthermia].
Hackl W; Winkler M; Mauritz W; Steinbereithner K
Anaesthesist; 1989 Dec; 38(12):681-5. PubMed ID: 2619030
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia.
Bendahan D; Guis S; Monnier N; Kozak-Ribbens G; Lunardi J; Ghattas B; Mattei JP; Cozzone PJ
Acta Anaesthesiol Scand; 2004 Sep; 48(8):1019-27. PubMed ID: 15315621
[TBL] [Abstract][Full Text] [Related]
7. Verapamil is not a therapeutic adjunct to dantrolene in porcine malignant hyperthermia.
Gallant EM; Foldes FF; Rempel WE; Gronert GA
Anesth Analg; 1985 Jun; 64(6):601-6. PubMed ID: 4003778
[TBL] [Abstract][Full Text] [Related]
8. Masseter muscle rigidity and malignant hyperthermia susceptibility.
Rosenberg H; Fletcher JE
Anesth Analg; 1986 Feb; 65(2):161-4. PubMed ID: 3942303
[TBL] [Abstract][Full Text] [Related]
9. The Israeli Diagnostic Center for Malignant Hyperthermia: 7-years' accumulated experience.
Glauber V; Ben Abraham R; Zweig A; Perel A
Isr J Med Sci; 1997 Oct; 33(10):643-7. PubMed ID: 9397136
[TBL] [Abstract][Full Text] [Related]
10. Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility.
Johannsen S; Klingler W; Schneiderbanger D; Heiderich S; Roewer N; Schuster F
Acta Anaesthesiol Scand; 2013 Oct; 57(9):1161-6. PubMed ID: 23957432
[TBL] [Abstract][Full Text] [Related]
11. Muscle biopsy for malignant hyperthermia screening in children.
Ummenhofer W; Roesslein R; Sutter PM; Moser N; Kern C; Urwyler A
Eur J Pediatr Surg; 1997 Oct; 7(5):259-62. PubMed ID: 9402480
[TBL] [Abstract][Full Text] [Related]
12. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1).
Roberts MC; Mickelson JR; Patterson EE; Nelson TE; Armstrong PJ; Brunson DB; Hogan K
Anesthesiology; 2001 Sep; 95(3):716-25. PubMed ID: 11575546
[TBL] [Abstract][Full Text] [Related]
13. [The effect of muscle relaxants on masseter tone. An experimental study in an MH-susceptible swine model].
Jantzen JP; Eberle B; Gaida BJ; Hennes HJ; Otto S; Schäfer M
Anaesthesist; 1992; 41(5):248-53. PubMed ID: 1616114
[TBL] [Abstract][Full Text] [Related]
14. Malignant hyperthermia in a Greyhound.
Bagshaw RJ; Cox RH; Knight DH; Detweiler DK
J Am Vet Med Assoc; 1978 Jan; 172(1):61-2. PubMed ID: 624662
[TBL] [Abstract][Full Text] [Related]
15. Malignant hyperthermia in humans--standardization of contracture testing protocol.
Melton AT; Martucci RW; Kien ND; Gronert GA
Anesth Analg; 1989 Oct; 69(4):437-43. PubMed ID: 2782643
[TBL] [Abstract][Full Text] [Related]
16. [Malignant hyperthermia; two cases of MH in the presence of general anesthesia and performing caffeine contracture test].
Tateishi M; Sumita S; Watanabe H; Kumeta H; Narimatsu E; Namiki A
Masui; 1989 Apr; 38(4):546-51. PubMed ID: 2724520
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR
Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of susceptibility to malignant hyperthermia in children].
Krivosic-Horber R; Adnet P; Krivosic I; Reyford H
Arch Fr Pediatr; 1990; 47(6):421-4. PubMed ID: 2403268
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of susceptibility to malignant hyperthermia using the in vitro contracture test].
Klein W; Spiess-Kiefer C; Küther G; Pongratz D; Lehmann-Horn F
Anaesthesist; 1987 Dec; 36(12):685-91. PubMed ID: 2830805
[TBL] [Abstract][Full Text] [Related]
20. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
